Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. / Macdonald, J.H.; Marcora, S.M.; Jibani, M.M. et al.
Yn: Nephron Clinical Practice, Cyfrol 106, Rhif 3, 01.07.2007, t. 125-135.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Macdonald, JH, Marcora, SM, Jibani, MM, Kumwenda, MJ, Ahmed, W & Lemmey, AB 2007, 'Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.', Nephron Clinical Practice, cyfrol. 106, rhif 3, tt. 125-135. https://doi.org/10.1159/000103000

APA

Macdonald, J. H., Marcora, S. M., Jibani, M. M., Kumwenda, M. J., Ahmed, W., & Lemmey, A. B. (2007). Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. Nephron Clinical Practice, 106(3), 125-135. https://doi.org/10.1159/000103000

CBE

Macdonald JH, Marcora SM, Jibani MM, Kumwenda MJ, Ahmed W, Lemmey AB. 2007. Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. Nephron Clinical Practice. 106(3):125-135. https://doi.org/10.1159/000103000

MLA

Macdonald, J.H. et al. "Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.". Nephron Clinical Practice. 2007, 106(3). 125-135. https://doi.org/10.1159/000103000

VancouverVancouver

Macdonald JH, Marcora SM, Jibani MM, Kumwenda MJ, Ahmed W, Lemmey AB. Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. Nephron Clinical Practice. 2007 Gor 1;106(3):125-135. doi: 10.1159/000103000

Author

Macdonald, J.H. ; Marcora, S.M. ; Jibani, M.M. et al. / Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. Yn: Nephron Clinical Practice. 2007 ; Cyfrol 106, Rhif 3. tt. 125-135.

RIS

TY - JOUR

T1 - Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.

AU - Macdonald, J.H.

AU - Marcora, S.M.

AU - Jibani, M.M.

AU - Kumwenda, M.J.

AU - Ahmed, W.

AU - Lemmey, A.B.

PY - 2007/7/1

Y1 - 2007/7/1

KW - UROLOGY & NEPHROLOGY

U2 - 10.1159/000103000

DO - 10.1159/000103000

M3 - Article

VL - 106

SP - 125

EP - 135

JO - Nephron Clinical Practice

JF - Nephron Clinical Practice

SN - 1660-2110

IS - 3

ER -